A disorder of angiogenesis leading to arteriovenous dilatations: cutaneo-mucosal hemorrhagic telangiectasias and visceral shunting.
Comprehensive, easy-to-understand information about this condition
How we create this content →Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Connect with organizations supporting the hereditary hemorrhagic telangiectasia community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Castle Creek Biosciences, LLC
Other
Consejo Superior de Investigaciones Cientificas
Other
Diagonal Therapeutics
Other
HHT Foundation International (d/b/a Cure HHT)
Other
Kamari Pharma Ltd.
Other
Laboratoires Delbert SAS
Other
PlumeStars s.r.l.
Other
Swedish Orphan Biovitrum AB (publ)
Other
Terence M. Davidson, MD
Other
Vaderis Therapeutics AG
Other